Startups

Crainio logo

Crainio

London, United Kingdom

Crainio develops a non-invasive brain-monitoring device intended to detect intracranial hypertension, including in patients with traumatic brain injury. A small forehead sensor uses low-power near-infrared light to record cerebral pulse signals; signal processing and machine-learning algorithms analyze those signals to identify elevated pressure inside the skull. The company designs the system for continuous monitoring and a simple hypertension indication, aiming to make brain-pressure assessment accessible beyond invasive monitoring in intensive care. It is a London-based medical-device company originating from optical-sensing research at City, University of London. Its current development program includes a multisite clinical feasibility study and research into monitoring during ambulance transfers. The company lists pivotal testing and regulatory approval as future steps, so the product remains in clinical development. Its legal company is Crainio Limited, incorporated in 2022.

Founded 2022

Team

Alex StokoeHead of Product
Chadi HajjHead of Data Science
Christopher UffChief Medical Officer
Ileana LindemanAdvisor and Statutory Director
Jeremy HollandFormer Chief Executive Officer (departure announced July 2026; exact end date undisclosed)
Maria Roldan RestrepoChief Executive Officer and Founder
Nicky OwenPatient advocate
Ozgun MavukClinical Research Assistant
Panicos KyriacouChief Scientific Officer and Founder
Sara LombardiSignal Processing Engineer
Tim CookeAdvisor and Statutory Director
Yoana BobevaClinical Research Assistant

Investments

$—2025-08-01NLC Health Ventures